Overview

Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
Identification and evaluation of endogenous markers for the assessment of CYP3A activity in female subjects using metabolomics
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Ketoconazole
Midazolam
Rifampin